246 related articles for article (PubMed ID: 32035650)
1. [Stereotaxic ablative radiotherapy in stage 1 non-small-cell lung cancer: Results of the phase 3 randomized trial "CHISEL"].
Gerard M; Lerouge D; Le Guevelou J; Thariat J
Bull Cancer; 2020 Feb; 107(2):145-147. PubMed ID: 32035650
[No Abstract] [Full Text] [Related]
2. Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: A critical literature review of predictive factors of relapse.
Loganadane G; Martinetti F; Mercier O; Krhili S; Riet FG; Mbagui R; To H; Le Péchoux C; Levy A
Cancer Treat Rev; 2016 Nov; 50():240-246. PubMed ID: 27768919
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of oligometastatic or oligoprogression cancer].
Bourgier C; Latorzeff I; Fenoglietto P; Boisselier P; Charissoux M; Llacer C; Lemanski C; Riou O; Farcy-Jacquet MP; Azria D
Cancer Radiother; 2019 Oct; 23(6-7):482-485. PubMed ID: 31495737
[TBL] [Abstract][Full Text] [Related]
4. [Stereotactic radiotherapy of stage I non-small cell lung cancer. State of the art in 2019 and recommendations: Stereotaxy as an alternative to surgery?].
Kaiss H; Mornex F
Cancer Radiother; 2019 Oct; 23(6-7):720-731. PubMed ID: 31471255
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic body radiotherapy (SBRT) for Stage I lung cancer.
Nagata Y; Kimura T
Jpn J Clin Oncol; 2018 May; 48(5):405-409. PubMed ID: 29635536
[TBL] [Abstract][Full Text] [Related]
6. [Stereotactic radiotherapy for localized primary lung tumours of stage T1-T2].
Boisselier P; Coutte A; Martin E; Pointreau Y
Cancer Radiother; 2022 Oct; 26(6-7):755-759. PubMed ID: 36075829
[TBL] [Abstract][Full Text] [Related]
7. [Proton therapy in advanced lung cancer, a clinical phase III trial].
Kao W; Thariat J
Bull Cancer; 2018; 105(7-8):634-635. PubMed ID: 29887286
[No Abstract] [Full Text] [Related]
8. [Stereotactic radiotherapy for operable stage I non-small cell lung cancer].
Martin É; Nicolet C; Boisselier P; Khalifa J; Thureau S
Cancer Radiother; 2023 Sep; 27(6-7):648-652. PubMed ID: 37563012
[TBL] [Abstract][Full Text] [Related]
9. Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non-small cell lung cancer: A virtual randomized phase III trial stratified by age.
Seo YS; Kim HJ; Wu HG; Choi SM; Park S
Thorac Cancer; 2019 Jun; 10(6):1489-1499. PubMed ID: 31124275
[TBL] [Abstract][Full Text] [Related]
10. [Current Status of Stereotactic Ablative Radiotherapy (SABR) for Early-stage
Non-small Cell Lung Cancer].
Shi A; Zhu G
Zhongguo Fei Ai Za Zhi; 2016 Jun; 19(6):389-93. PubMed ID: 27335303
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer.
Maquilan G; Timmerman R
Cancer J; 2016; 22(4):274-9. PubMed ID: 27441747
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
Iyengar P; Westover K; Timmerman RD
Semin Respir Crit Care Med; 2013 Dec; 34(6):845-54. PubMed ID: 24258574
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
Hadziahmetovic M; Loo BW; Timmerman RD; Mayr NA; Wang JZ; Huang Z; Grecula JC; Lo SS
Discov Med; 2010 May; 9(48):411-7. PubMed ID: 20515609
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer in the elderly.
Shinde A; Li R; Kim J; Salgia R; Hurria A; Amini A
Semin Oncol; 2018 Aug; 45(4):210-219. PubMed ID: 30286944
[TBL] [Abstract][Full Text] [Related]
15. Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review.
Tandberg DJ; Tong BC; Ackerson BG; Kelsey CR
Cancer; 2018 Feb; 124(4):667-678. PubMed ID: 29266226
[TBL] [Abstract][Full Text] [Related]
16. Forecasting the impact of stereotactic ablative radiotherapy for early-stage lung cancer on the thoracic surgery workforce.
Edwards JP; Datta I; Hunt JD; Stefan K; Ball CG; Dixon E; Grondin SC
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1599-606. PubMed ID: 26796110
[TBL] [Abstract][Full Text] [Related]
17. Management of Stage I Lung Cancer with Stereotactic Ablative Radiation Therapy.
Dan T; Williams NL
Surg Oncol Clin N Am; 2017 Jul; 26(3):393-403. PubMed ID: 28576179
[TBL] [Abstract][Full Text] [Related]
18. Surgery and stereotactic body radiotherapy for early-stage non-small cell lung cancer: prospective clinical trials of the past, the present, and the future.
Hamaji M
Gen Thorac Cardiovasc Surg; 2020 Jul; 68(7):692-696. PubMed ID: 31667707
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer.
Abbas G; Danish A; Krasna MJ
Surg Oncol Clin N Am; 2016 Jul; 25(3):553-66. PubMed ID: 27261915
[TBL] [Abstract][Full Text] [Related]
20. Canadian Phase III Randomized Trial of Stereotactic Body Radiotherapy Versus Conventionally Hypofractionated Radiotherapy for Stage I, Medically Inoperable Non-Small-Cell Lung Cancer - Rationale and Protocol Design for the Ontario Clinical Oncology Group (OCOG)-LUSTRE Trial.
Swaminath A; Wierzbicki M; Parpia S; Wright JR; Tsakiridis TK; Okawara GS; Kundapur V; Bujold A; Ahmed N; Hirmiz K; Kurien E; Filion E; Gabos Z; Faria S; Louie AV; Owen T; Wai E; Ramchandar K; Chan EK; Julian J; Cline K; Whelan TJ
Clin Lung Cancer; 2017 Mar; 18(2):250-254. PubMed ID: 27876603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]